COLL
Collegium Pharmaceutical Inc

1,572
Loading...
Loading...
Upcoming Earnings: Q3 '25
Reports: Nov 06,
Pre-Market

Estimated EPS

$1.88

Estimated Rev

$191.25M

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '25
$1.88
--
--
N/A
Q2 '25
$1.62
$1.68
3.92%
BEAT
Q1 '25
$1.43
$1.49
4.01%
BEAT
Q4 '24
$1.54
$1.77
15.11%
BEAT
Q3 '24
$1.59
$1.61
1.16%
BEAT

Latest COLL News

View

Advertisement. Remove ads.

Advertisement. Remove ads.